Literature DB >> 11027815

Plasmodium falciparum AMA-1 erythrocyte binding peptides implicate AMA-1 as erythrocyte binding protein.

M Urquiza1, J E Suarez, C Cardenas, R Lopez, A Puentes, F Chavez, J C Calvo, M E Patarroyo.   

Abstract

The role of AMA-1 during merozoite invasion has not yet been determined. However, reported experimental evidence suggests that this protein can be used, in particular as erythrocyte-binding protein, since, Fab fragments against this protein are able to block merozoite invasion. Using a previously described methodology, eight peptides with high binding activity to human erythrocyte, scattered along the different domains and having around 130 nM affinity constants, were identified in the Plasmodium falciparum AMA-1 protein. Their binding activity was sialic acid independent. Some of these peptides showed homology with the erythrocyte binding domains of one of the apical organelle protein family, MAEBL, identified in rodent malarial parasites. One of these peptides shares amino acid sequence with a previously reported B-cell epitope which induces antibodies to block parasite growth. The critical residues were identified for erythrocyte binding conserved peptides 4313 (DAEVAGTQYRLPSGKCPVFG), 4321 (VVDNWEKVCPRKNLQNAKFG), 4325 (MIKSAFLPTGAFKADRYKSH) and 4337 (WGEEKRASHTTPVLMEKPYY). All conserved peptides were able to block merozoite invasion of new RBC and development, suggesting that these peptides are involved in P. falciparum invasion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027815     DOI: 10.1016/s0264-410x(00)00185-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

1.  Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1.

Authors:  Markus S Mueller; Annabelle Renard; Francesca Boato; Denise Vogel; Martin Naegeli; Rinaldo Zurbriggen; John A Robinson; Gerd Pluschke
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

2.  Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum.

Authors:  Sheetij Dutta; J David Haynes; Arnoldo Barbosa; Lisa A Ware; Jeffrey D Snavely; J Kathleen Moch; Alan W Thomas; David E Lanar
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

3.  Conditional expression of Toxoplasma gondii apical membrane antigen-1 (TgAMA1) demonstrates that TgAMA1 plays a critical role in host cell invasion.

Authors:  Jeffrey Mital; Markus Meissner; Dominique Soldati; Gary E Ward
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

Review 4.  Peptides for Vaccine Development.

Authors:  Ian W Hamley
Journal:  ACS Appl Bio Mater       Date:  2022-02-23

5.  Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells.

Authors:  G H Mitchell; A W Thomas; G Margos; A R Dluzewski; L H Bannister
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Protein kinase a dependent phosphorylation of apical membrane antigen 1 plays an important role in erythrocyte invasion by the malaria parasite.

Authors:  Kerstin Leykauf; Moritz Treeck; Paul R Gilson; Thomas Nebl; Thomas Braulke; Alan F Cowman; Tim W Gilberger; Brendan S Crabb
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

7.  Erythrocyte invasion by Babesia bovis merozoites is inhibited by polyclonal antisera directed against peptides derived from a homologue of Plasmodium falciparum apical membrane antigen 1.

Authors:  Fasila R Gaffar; Ana P Yatsuda; Frits F J Franssen; Erik de Vries
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.

Authors:  Kazutoyo Miura; Suwani Perera; Sarah Brockley; Hong Zhou; Joan A Aebig; Samuel E Moretz; Louis H Miller; Ogobara K Doumbo; Issaka Sagara; Alassane Dicko; Ruth D Ellis; Carole A Long
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

Review 9.  Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines.

Authors:  M E Patarroyo; G Cifuentes; A Bermúdez; M A Patarroyo
Journal:  J Cell Mol Med       Date:  2008-10       Impact factor: 5.310

10.  An Extended Surface Loop on Toxoplasma gondii Apical Membrane Antigen 1 (AMA1) Governs Ligand Binding Selectivity.

Authors:  Michelle L Parker; Martin J Boulanger
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.